THERAPEUTIC USE OF INTER-ALPHA INHIBITOR IN SEPSIS

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$1,501,420.00
Award Year:
2004
Program:
SBIR
Phase:
Phase II
Contract:
2R44GM065667-02
Agency Tracking Number:
GM065667
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
PROTHERA BIOLOGICS, LLC
PROTHERA BIOLOGICS, LLC, 87 WALMER AVE, EAST PROVIDENCE, RI, 02914
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 YOWPIN Lim
 (401) 301-2046
 YOW-PIN_LIM_MD@BROWN.EDU
Business Contact
 M YOW-PIN LIM
Phone: (401) 301-2056
Email: YOW-PIN_LIM_MD@BROWN.EDU
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The goal of the proposed research is to demonstrate that Inter-alpha serine protease inhibitor proteins (IaIp) are an effective therapy for sepsis. In sepsis, normally high plasma levels of IaIp drop dramatically in

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government